Fine-Needle Aspiration (FNA / FNAC): What It Shows, What It Cannot, and What to Expect

Key takeaways

• FNAC samples cells, not tissue architecture: it answers "what type of cells are these?", not always "how far has this spread?"
• A benign or negative FNAC does not exclude cancer: the needle may have missed the abnormal area; persistent or growing lumps need review.
• Imaging guidance matters: ultrasound- or CT-guided FNA is generally more reliable than a blind palpation-guided pass for small or deep lesions.
• Risk differs by site: a neck node FNA and a lung or liver FNA do not carry the same risk profile.
• Preparation is unit-specific: fasting, sedation and blood-thinner instructions depend on the site, the guidance method and your hospital's protocol.

At a glance

Also known as

• FNAC, fine-needle aspiration cytology (the usual term in Indian laboratories and reports)
• Needle test / sui se test / "needle biopsy" in everyday speech
• USG-guided FNAC, sonography-guided FNAC
• Thyroid FNAC, breast FNAC, lymph node FNAC
• EUS-FNA (endoscopic ultrasound-guided FNA) for pancreas and deep abdominal nodes

What fine-needle aspiration is

Fine-needle aspiration is a cytology procedure. A needle finer than the one used for a blood sample is passed into a lump, moved gently back and forth to dislodge cells, and the material is smeared on slides or placed in fluid for the cytopathologist to examine. Some laboratories also prepare a cell block, which allows limited additional staining.

FNAC differs from a core needle biopsy, which uses a wider cutting needle to remove a small cylinder of tissue with its structure intact. That structural detail matters for some diagnoses, which is why FNAC is not interchangeable with core biopsy.

Why fine-needle aspiration is done

• To characterise a lump: to see whether the cells look benign, inflammatory, suspicious or malignant.
• To investigate infection: particularly enlarged neck lymph nodes, where tuberculosis is a common cause in India; aspirated material can be sent for AFB smear, GeneXpert/NAAT and mycobacterial culture as well as cytology.
• To drain and assess a cyst: aspirating a cyst may relieve symptoms and provide fluid for examination.
• To confirm recurrence or spread: sampling a node or nodule in someone with a known cancer.
• To guide the next step: whether to observe, treat medically, or proceed to surgery or a larger biopsy.

Who should consider this test

Fine-needle aspiration is usually advised by the treating doctor when a specific question needs answering. Situations where FNAC is commonly considered include:

• A thyroid nodule that meets size and ultrasound-risk criteria for sampling (ultrasound pattern, not size alone, drives the decision in current thyroid guidance).
• A neck, axillary or groin lymph node that stays enlarged for several weeks, is firm, or is enlarging.
• A breast lump or an imaging abnormality where the breast team judges cytology appropriate, though in many breast pathways a core biopsy is preferred because it gives receptor status.
• A salivary gland swelling, or a soft-tissue lump under the skin.
• A lesion in the liver, lung, pancreas or abdomen seen on imaging, where tissue confirmation is needed and image-guided sampling is feasible.

FNAC may be deferred or replaced by another test if you have an uncorrected bleeding tendency, if the lesion is in a position that cannot be reached safely, or if the clinical question needs architecture or molecular testing that cytology cannot provide. The decision belongs to the clinician examining you.

What fine-needle aspiration cannot detect or exclude

Being clear about limits prevents false reassurance.

• A negative or benign FNAC does not exclude cancer. The needle samples a small part of the lump. A false-negative can happen if the needle misses the abnormal area, if the lesion is largely necrotic or cystic, or if the cells are fragile. If the lump persists, grows or changes despite a benign result, go back to your doctor.
• FNAC cannot always distinguish benign from malignant follicular thyroid lesions. Follicular pattern cytology is a known grey zone; distinguishing follicular adenoma from follicular carcinoma requires examination of capsular invasion on surgical tissue.
• FNAC does not reliably assess tissue architecture. It cannot grade most tumours confidently, cannot assess invasion, and cannot stage disease.
• FNAC often cannot subtype lymphoma on its own. Flow cytometry on the aspirate helps, but definitive lymphoma classification usually needs a core or excision biopsy.
• Cytology may be insufficient for full molecular and receptor testing. Breast hormone receptor and HER2 testing, and many lung cancer molecular panels, are typically performed on core biopsy or cell-block material; sometimes a repeat sample is required.
• A "non-diagnostic" or "inadequate" report is not a normal result. It means not enough diagnostic cells were obtained and the question remains open.
• FNAC does not tell you why a node is enlarged if the aspirate shows only reactive change. Reactive cytology is common and non-specific.

Related but different examinations

None of these is universally superior. Which comes first depends on the organ, the suspected diagnosis and what test the material must undergo. For a suspicious thyroid nodule, FNAC is usually the sampling method of choice. For a suspected lymphoma or a breast cancer needing receptor status, a core biopsy is generally more appropriate.

How to prepare

Preparation is operational and varies between hospitals, departments and sites sampled. Your unit's written instructions take precedence over any general guidance, including this page.

• Bring your records: previous scans, earlier cytology or biopsy reports, and a current medicine list.
• Declare blood thinners and bleeding problems: aspirin, clopidogrel, warfarin, newer oral anticoagulants, or a known clotting disorder. Do not stop any prescribed medicine on your own; ask the prescribing doctor, who will balance bleeding risk against the risk of stopping.
• Superficial FNAC usually needs no fasting: thyroid, neck node, breast and skin lumps are commonly done without fasting.
• Fasting and consent apply mainly to deep or sedated procedures: liver, lung, pancreas, EUS-FNA.
• Dress practically: clothing that allows easy access to the area; you may be asked to remove neck jewellery for a thyroid FNAC.
• Arrange an escort if sedation is planned.

If you are pregnant or might be

Tell the team before the procedure. Ultrasound-guided FNAC of a superficial lump does not use radiation and is often feasible in pregnancy. CT-guided sampling involves ionising radiation and is considered only when clearly justified. Timing may be adjusted in discussion with your obstetrician.

If you have diabetes on glucose-lowering treatment

If fasting is required, ask the prescriber in advance how to handle insulin or tablets on the day, and carry glucose with you. Do not fast for long periods on your usual dose without that advice.

If you have chronic kidney disease, heart failure or a fluid restriction

Standard FNAC needs no contrast and no fluid loading. If a contrast-enhanced scan is planned alongside the procedure, tell the team about your kidney function, dialysis schedule or fluid limits so the plan can be adjusted.

Children

Paediatric FNAC is usually done in a child-friendly setting, sometimes with topical anaesthetic or light sedation depending on age, cooperation and site. A parent is generally allowed to stay. Discuss sedation arrangements beforehand.

Older adults

Positioning and time on the couch may be the main practical issues. Mention neck or spine stiffness, hearing difficulty, or an inability to lie flat, so the team can plan.

What happens during fine-needle aspiration

The sequence for a typical superficial FNAC:

• Consent and checks: the site is confirmed, allergies and blood thinners reviewed.
• Positioning: for a thyroid FNAC you usually lie with the neck slightly extended.
• Cleaning and anaesthesia: the skin is cleaned. Local anaesthetic is used for many sites; some superficial thyroid and node aspirates are done without it, because the anaesthetic injection can sting as much as the aspiration needle.
• Needle passes: the needle is inserted, moved gently to collect cells, then withdrawn. Two to four passes are common to obtain enough material. You may be asked not to swallow or talk during a thyroid pass.
• Slide preparation: material is spread on slides; in some units a cytotechnologist or pathologist checks adequacy on the spot.
• Pressure and dressing: firm pressure is applied for a few minutes, then a small dressing.
• Observation: brief for superficial sites; longer, sometimes with a chest X-ray, after lung sampling.

How long the process takes

• Needle sampling itself: a few minutes.
• Superficial FNAC visit: commonly around 15-30 minutes in the room, plus registration and paperwork.
• Image-guided deep FNA: longer, because of planning scans, positioning and post-procedure observation; EUS-FNA involves sedation recovery time as well.
• Report: cytology reporting time depends on the laboratory, whether special stains, cell block, microbiology or flow cytometry are added, and whether a second opinion is sought. Ask your unit when to expect the report and how you will receive it.

Understanding your report

FNAC has no "normal range". The report is a descriptive and interpretive opinion on the cells seen. Most reports fall into recognisable categories:

Site-specific structured reporting systems are widely used, for example the Bethesda system for thyroid cytopathology, the Milan system for salivary gland cytology and the IAC Yokohama system for breast cytology. Each category in these systems carries a different implied risk and a different recommended next step, and the editions are periodically revised. Ask the clinician who requested the test what your specific category means for you. Results vary depending on individual clinical circumstances, and no FNAC report should be read in isolation from examination and imaging.

No result on this page amounts to a diagnosis. Interpretation belongs to the doctor who requested the test.

When results can be misleading

When FNAC can falsely suggest no cancer (false negative)

• The needle missed the abnormal focus in a large, heterogeneous or partly cystic lesion.
• The lesion is mostly necrotic, fibrotic or sclerotic and yields few intact cells.
• Sampling was palpation-guided for a small or deep lump.
• Low-grade tumours can shed cells that look deceptively bland, notably some follicular thyroid lesions and low-grade lymphomas.
• Smearing, air-drying or fixation problems degrade the cells.

When FNAC can falsely suggest cancer (false positive)

• Marked reactive or reparative change, or recent inflammation, can mimic malignant features.
• Radiation or chemotherapy changes can cause atypia.
• Very cellular benign lesions may be over-called; this is one reason "suspicious" rather than "malignant" is often reported.

Other sources of error

• Blood-diluted aspirate: obscures cells and lowers adequacy.
• Sampling the wrong target: for example an adjacent reactive node rather than the suspicious one.
• Missing clinical information: cytology is interpreted better when the pathologist knows the history, site and imaging findings.
• Interpretation is observer-dependent: cytology involves pattern recognition, and expert opinions can differ, especially in indeterminate categories. A second opinion is reasonable in difficult cases.

Risks and safety

FNAC is low-risk overall, but risk is not identical across all sites, so it should not be described with one blanket statement.

Superficial FNAC: thyroid, breast, lymph node, salivary gland, soft tissue

Common and usually minor: brief pain, tenderness for a day or two, small bruise or haematoma, light bleeding at the puncture site. Uncommon: infection at the site, a larger haematoma, transient swelling of a thyroid nodule, or vasovagal faintness. Very uncommon: injury to a nearby nerve or vessel.

Lung and mediastinal FNA

Additional risks include pneumothorax (air leak around the lung), which sometimes needs a drain, and coughing up small amounts of blood. Observation and a follow-up chest X-ray are usual. Risk is higher with small, deep lesions and in significant emphysema.

Liver, kidney, pancreas and other deep abdominal FNA

Bleeding is the main concern, and blood-thinning medicines and clotting status are reviewed beforehand. Other uncommon risks include pain, infection, bile leak after liver sampling and pancreatitis after pancreatic sampling. Needle-track seeding of tumour cells is a recognised but rare consideration discussed for certain lesions.

Sedation-related

Where sedation is used, drowsiness, nausea and breathing depression are possible; monitoring is standard. Pre-existing sleep apnoea, heart or lung disease should be declared.

Special situations

Pregnancy and breastfeeding

A new breast or thyroid lump in pregnancy or during breastfeeding still needs assessment and should not be dismissed as hormonal. Ultrasound-guided sampling avoids radiation. Breastfeeding can usually continue; confirm with the team, particularly after a breast procedure. Note that PC-PNDT Act, 1994 provisions govern ultrasound use in India and prohibit any use of ultrasound for sex determination of a fetus; diagnostic ultrasound guidance for a lump is unrelated to that purpose but is performed only in registered facilities by authorised personnel.

Children and adolescents

Persistent neck node enlargement is common in children and frequently reactive or tubercular rather than malignant. FNAC can be very useful, but sedation needs, smaller targets and the value of sending material for tuberculosis testing all influence planning.

People on anticoagulants or antiplatelets

Superficial FNAC is often still possible on treatment with careful compression. Deep-organ sampling usually requires a plan agreed with the prescriber. Never stop these medicines on your own, the risk of clot or stroke may outweigh the bleeding risk.

People with known cancer

FNAC of a new node or nodule can confirm recurrence or spread quickly. However, if treatment decisions depend on receptor or molecular testing, a core biopsy may be requested instead or in addition.

Immunosuppressed patients

Infection risk deserves extra attention, and the range of possible diagnoses widens, atypical infections and tuberculosis are more likely, so microbiological testing of the aspirate is often added.

Fine-needle aspiration in the Indian context

• FNAC is the everyday term. Indian requisition forms and reports usually read "FNAC" or "USG-guided FNAC"; sonography and USG are used interchangeably.
• Tuberculosis changes the interpretation of nodal cytology. India carries a large share of the global tuberculosis burden (see the World Health Organization Global Tuberculosis Report for current country figures). Because of this, granulomatous or necrotising cytology from a lymph node commonly triggers AFB staining, molecular testing such as GeneXpert and mycobacterial culture on the aspirate. Ask for these if a tubercular cause is being considered, cytology alone does not confirm drug sensitivity.
• Iodine status and thyroid nodules. Thyroid nodules are frequently detected on neck ultrasound; most are benign. Ultrasound features, not nodule size alone, guide whether FNAC is needed.
• Ask where the slides are read. Cytology quality depends heavily on the person taking the sample and the pathologist reading it. It is reasonable to ask whether the aspiration is image-guided and whether a cytopathologist is involved.
• Keep your slides and blocks traceable. If you may seek a second opinion or treatment elsewhere, ask the laboratory about retrieving slides and cell blocks.
• Data protection. Reports and images are personal health data; the Digital Personal Data Protection Act, 2023 governs how Indian facilities collect and process them, and you can ask how your records are stored and shared.

Cost and insurance in India

Costs differ widely between government, trust and private facilities and between cities. Rather than a single figure, it is more useful to know what drives the price:

• Guidance method: palpation-guided FNAC is the least expensive; USG-guided costs more; CT-guided and EUS-FNA cost substantially more because of equipment, sedation and staffing.
• Site and complexity: deep-organ sampling needs a procedure suite and observation.
• Number of sites sampled: each target is usually charged separately.
• Add-on laboratory tests: cell block, special stains, immunocytochemistry, flow cytometry, AFB smear, GeneXpert, culture and molecular tests are billed in addition to basic cytology.
• Sedation or anaesthesia charges, and day-care bed charges where applicable.
• Repeat procedures if the first sample is inadequate.
• Expert review or second opinion on slides.

On insurance: outpatient diagnostic procedures are frequently not reimbursed under standard indemnity policies unless linked to an admission or covered by a specific outpatient or day-care benefit. Under government schemes such as Ayushman Bharat PM-JAY, eligible beneficiaries may receive covered investigations at empanelled hospitals within the defined packages. Confirm coverage, pre-authorisation requirements and any package inclusions with the hospital billing desk and your insurer before the procedure. Ask for an itemised estimate that separates the procedure fee, imaging guidance and laboratory tests.

Myths and facts

Frequently asked questions

Is FNAC the same as FNA?

Yes in everyday use. FNA describes the act of aspirating with a fine needle; FNAC adds "cytology", the microscopic examination of the aspirated cells. Indian laboratories usually write FNAC on forms and reports. Both refer to the same procedure and the same type of sample.

Does a benign FNAC report mean I do not have cancer?

Not with certainty. A benign report means the cells obtained looked non-cancerous. The needle samples only part of the lump, so a small cancer can be missed. If the lump persists, enlarges, hardens or changes, return to your doctor for reassessment rather than relying on the earlier report.

Why did my doctor order a core biopsy instead of FNAC?

Core biopsy gives a tissue core with intact architecture, which is often needed for lymphoma classification, sarcoma diagnosis, assessment of invasion, and breast hormone receptor and HER2 testing. Where those answers are required, core biopsy is usually the more appropriate first sampling method rather than cytology.

What does an inconclusive or inadequate FNAC mean?

It means too few diagnostic cells were obtained, so the clinical question remains unanswered. It is not a negative result. Your doctor may recommend a repeat aspiration under ultrasound guidance, a core biopsy, or continued imaging follow-up, depending on how suspicious the lesion looks clinically.

Can I go to work after the procedure?

After a superficial FNAC, most people return to routine activity the same day, avoiding heavy lifting or strenuous exercise briefly as advised. After sedation or deep-organ sampling, plan for rest, an escort home and a longer gap before resuming work. Follow the specific instructions your unit gives you.

Should I stop my blood thinner before FNAC?

Do not change any prescribed medicine yourself. Tell the team you take it, and ask the prescribing doctor. Many superficial aspirations can proceed on treatment with careful compression, while deep-organ sampling may need a planned adjustment. Stopping anticoagulants without advice can carry serious clot or stroke risk.

Can FNAC diagnose tuberculosis in a neck lump?

Cytology can strongly suggest tuberculous lymphadenitis when granulomas and necrosis are seen, but cytology alone is not confirmatory. Aspirated material should also go for AFB smear, a molecular test such as GeneXpert and mycobacterial culture, which can confirm the organism and identify drug resistance.

How many needle passes will be needed?

Usually two to four, though this varies with the lesion and whether adequacy is checked on the spot. More passes improve the chance of a diagnostic sample. The operator balances sample adequacy against your comfort and any bleeding at the site.

Is ultrasound-guided FNAC better than the one done by feeling the lump?

For small, deep, partly cystic or ultrasound-suspicious lesions, guided sampling targets the needle more precisely and generally yields fewer inadequate samples. For a large, easily felt superficial lump, palpation-guided FNAC may be sufficient. The choice depends on the lesion, not on cost alone.

Sources

• Ali SZ, Cibas ES (eds). The Bethesda System for Reporting Thyroid Cytopathology, definitions, criteria and explanatory notes. Springer. [Confirm current edition, TO BE VERIFIED]
• Faquin WC, Rossi ED (eds). The Milan System for Reporting Salivary Gland Cytopathology. Springer.
• Field AS, Schmitt F, Vielh P et al. The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology. Acta Cytologica.
• Haugen BR et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid.
• World Health Organization. Global Tuberculosis Report, country profile, India.
• Central TB Division, Ministry of Health and Family Welfare, Government of India. National guidelines on the diagnosis of extrapulmonary tuberculosis.
• Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, Government of India.
• Digital Personal Data Protection Act, 2023, Government of India.